会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 93. 发明申请
    • METHOD FOR FIXING CARBON DIOXIDE AND COMPOSITION THEREFOR
    • 固定二氧化碳及其组合物的方法
    • US20130206685A1
    • 2013-08-15
    • US13660587
    • 2012-10-25
    • Industry Foundation of Chonnam National University
    • Yul ROHSur Ku KANG
    • C02F3/32
    • C02F3/322C02F3/341C12N1/00
    • Provided is a method for biologically fixing carbon dioxide dissolved in contaminated water using a microorganism derived from rhodolith. The method includes enrichment-incubating a microorganism derived from rhodolith, and treating and reacting the enrichment-incubated microorganism in contaminated water to fix carbon dioxide dissolved in contaminated water as a carbonate mineral. The method for biologically fixing carbon dioxide has a simple fixing process and is environmentally friendly, compared with chemical carbon dioxide fixing technology. In addition, this method enables fast fixation of carbon dioxide even at room temperature, and thus can be easily applied in the industrial field, and is also useful in an aspect of resource recycling since the carbon dioxide is eventually fixed in the form of calcium carbonate.
    • 本发明提供一种使用来自玫瑰石的微生物将溶解在污染水中的二氧化碳进行生物固定的方法。 该方法包括富集培养来自玫瑰石的微生物,并将富集培养的微生物处理和反应在污染的水中以固定溶解在污染的水中的二氧化碳作为碳酸盐矿物。 与化学二氧化碳固定技术相比,生物固定二氧化碳的方法具有简单的定影过程并且是环境友好的。 此外,该方法即使在室温也能够快速固定二氧化碳,因此可以容易地应用于工业领域,并且在资源循环方面也是有用的,因为二氧化碳最终以碳酸钙的形式固定 。
    • 95. 发明申请
    • THERAPEUTIC MICROROBOT SYSTEM FOR BRAIN AND SPINAL CORD DISEASES
    • 用于脑和脊髓疾病的治疗微阵列系统
    • US20130060130A1
    • 2013-03-07
    • US13696720
    • 2012-04-05
    • Suk Ho ParkJong Oh ParkKyoung Rae Cha
    • Suk Ho ParkJong Oh ParkKyoung Rae Cha
    • A61B6/00
    • A61B6/12A61B6/037A61B6/466A61B6/481A61B6/504A61B34/10A61B34/30A61B34/70A61B34/72A61B34/73A61B2090/376
    • Disclosed is a microrobot for the therapy of brain/spinal cord diseases. It comprises a microrobot comprising a driving unit having a magnet therein, and a therapeutic means or drug delivery means for treating a disease lesion; a microrobot driving module for performing and controlling various motions of the microrobot by generating an electromagnetic force through an electromagnetic coil system; an imaging module for imaging a thecal sac filled with cerebrospinal fluid, a ventricle, and the microrobot; a diagnosis module for diagnosing the brain/spinal cord disease, based on a pre-operative image produced by the imaging module; and a navigation module for planning a moving path for the microrobot, based on the pre-operative image produced by the imaging module and for monitoring the microrobot through an intraoperative image produced by the imaging module.
    • 公开了用于治疗脑/脊髓疾病的微型机器人。 它包括一个包括其中具有磁体的驱动单元的微型机器人,以及用于治疗疾病病变的治疗装置或药物递送装置; 微型驾驶模块,用于通过电磁线圈系统产生电磁力来执行和控制所述微型机身的各种运动; 用于对填充有脑脊液,心室和微型机器的囊囊成像的成像模块; 基于由所述成像模块产生的术前图像的用于诊断脑/脊髓疾病的诊断模块; 以及导航模块,用于基于由所述成像模块产生的所述手术前图像来规划所述微机器的移动路径,并且用于通过所述成像模块产生的术中图像监视所述微机架。
    • 96. 发明申请
    • METHOD FOR DETERMINING GENOTOXICITY USING NON-FLUORESCENT PROTEINS
    • 使用非荧光蛋白测定细胞毒性的方法
    • US20130024955A1
    • 2013-01-24
    • US13578183
    • 2011-03-31
    • Hyon El ChoySeok-Yong Choi
    • Hyon El ChoySeok-Yong Choi
    • A61K49/00C12N15/12
    • G01N33/5014A01K67/0275A01K2217/052A01K2227/40A01K2267/0393G01N33/5088
    • The present invention relates to a method for determining a genotoxicity of a test substance, comprising the steps of: (a) transforming a fish with a nucleotide sequence encoding a non-fluorescent fluorescence protein with a mutation; (b) treating a test substance to the transformed fish; and (c) measuring a fluorescence in the test substance-treated fish, wherein the fluorescence is generated by reversion of the non-fluorescent fluorescence protein to the fluorescence protein due to a back mutation of the nucleotide sequence in the test substance-treated fish. According to the present invention, MutaFish system, Zebrafish (Brachydanio rerio) line, in which the fluorescence protein variant, preferably wild type EGFP variant (EGFPmut) is transformed, provides a much excellent animal system for measuring a genotoxicity of a test substance via production of a fluorescent fry larvae generated through reversion of the fluorescent protein variant caused by treatment of the test substance. Accordingly, the MutaFish system of the present invention may determine a genotoxicity of a test substance in much more simple and high-throughput manner in an eukaryote to which the conventional methods (e.g., Ames test) may be not applied.
    • 本发明涉及测定物质的基因毒性的方法,其特征在于,包括以下步骤:(a)用编码具有突变的非荧光荧光蛋白的核苷酸序列转化鱼; (b)将经检测的物质处理至经转化的鱼; 和(c)测定被检物质处理过的鱼中的荧光,其中,由于检测物质处理的鱼中的核苷酸序列的反向突变,通过将非荧光荧光蛋白逆转为荧光蛋白而产生荧光。 根据本发明,其中荧光蛋白变体,优选野生型EGFP变体(EGFPmut)被转化的MutaFish系统斑马鱼(Brachydanio rerio)系提供了非常优异的用于通过生产测量测试物质的基因毒性的动物系统 通过由测试物质的处理引起的荧光蛋白质变体的逆转产生的荧光鱼苗。 因此,本发明的MutaFish系统可以以更加简单和高通量的方式在常规方法(例如Ames测试)中不能应用的真核细胞中确定测试物质的基因毒性。
    • 97. 发明授权
    • Method and apparatus for setting a lip region for lip reading
    • 用于设置唇部读数的唇部区域的方法和装置
    • US08290277B2
    • 2012-10-16
    • US12646600
    • 2009-12-23
    • Seong-Taek HwangJin-Young Kim
    • Seong-Taek HwangJin-Young Kim
    • G06K9/46
    • G06K9/00248
    • A method for setting a lip region of a face included in an image, including setting a first region and a second region in an image including a face, identifying contrast information of the first region, setting a threshold for binarization using the contrast information, and binarizing the second region based on the threshold. A region in which a pixel having an identical binary value continuously distributed within a predetermined number of ranges in the binarized image is set as an eye candidate object. An eye region is then extracted from the eye candidate object based on geometric characteristic of an eye region in an image, and the lip region is set with reference to the extracted eye region based on geometric information of the eye region and the lip region.
    • 一种用于设置包括在图像中的脸部的唇部区域的方法,包括在包括脸部的图像中设置第一区域和第二区域,识别第一区域的对比度信息,使用对比度信息设置二值化阈值,以及 基于阈值二值化第二区域。 将其中在二值化图像中的预定数量范围内连续分布的相同二进制值的像素设置为候选对象的区域。 然后基于图像中的眼睛区域的几何特征,从眼睛候选物体中提取眼睛区域,并且基于眼睛区域和唇部区域的几何信息,参照提取的眼睛区域设定唇部区域。
    • 100. 发明授权
    • Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use
    • 5-氨基乙酰丙酸的不饱和烷基酯,其制备及其应用
    • US08198325B2
    • 2012-06-12
    • US12227085
    • 2007-06-28
    • Jonghoon OhJee-Bum LeeHyoung-Ryun Park
    • Jonghoon OhJee-Bum LeeHyoung-Ryun Park
    • A61K31/22C07C229/00
    • C07C229/22
    • Disclosed are unsaturated alkyl esters of 5-aminovulinic acid of the following chemical formula 1, or pharmaceutically acceptable salts thereof, a method for preparing the same, and uses thereof. [Chemical Formula I] NH2—CH2—CO—CH2—CH2—CO—O—R wherein, R is a group selected from a group consisting of 2-propenyl, 3-butenyl, 4-pentenyl, 5-hexenyl, cis-2-pentenyl, cis-3-hexenyl, cis-4-hexenyl, and trans-2-hexenyl. Also, a pharmaceutical composition comprising the unsaturated alkyl ester of 5-aminovulinic acid or a salt thereof as an active ingredient is provided. This pharmaceutical composition is easily absorbed transdermally and is of low cytotoxicity. Featuring no amino-protecting processes, the method guarantees high production yields.
    • 公开了以下化学式1的5-氨基丙烯酸的不饱和烷基酯或其药学上可接受的盐,其制备方法及其应用。 [化学式I] NH 2 -CH 2 -CO-CH 2 -CH 2 -CO-O-R其中,R是选自2-丙烯基,3-丁烯基,4-戊烯基,5-己烯基,顺式 - 2-戊烯基,顺式-3-己烯基,顺式-4-己烯基和反式-2-己烯基。 此外,提供了包含5-氨基乙酰丙酸的不饱和烷基酯或其盐作为活性成分的药物组合物。 该药物组合物容易被透皮吸收并具有低细胞毒性。 不具有氨基保护过程,该方法保证了高产量。